Joseph Sullivan, MD


Joseph Sullivan, MD: The Benefits of Fenfluramine Treatment in Dravet Syndrome

December 12, 2019

The professor of neurology and pediatrics and director of the Pediatric Epilepsy Center at the University of California, San Francisco, discussed his personal experience with fenfluramine and the advantages that the drug may present when treating patients with Dravet syndrome.

Joseph Sullivan, MD: Scientifically Determining a Clinically Meaningful Change in Seizure Frequency

January 19, 2019

The Director of the Pediatric Epilepsy Center at UCSF Benioff Children's Hospital spoke about what defines a "clinically meaningful change in seizure frequency" using data from a phase 3 clinical trial of ZX008 for the adjunctive treatment of seizures associated with Dravet syndrome.